Live Breaking News & Updates on Precision med

Stay informed with the latest breaking news from Precision med on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Precision med and stay connected to the pulse of your community

Celebrating National Robotics Week

Celebrating National Robotics Week
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Eric-topol , Jon-brennan-badal , Society-of-lab-automation , European-society-for-blood , National-robotics-week , European-committee , International-society , Gene-therapy , European-society , Precision-med , Lab-automation ,

Machines Bring Efficiency…and Empathy? Eric Topol Talks AI in Precision Medicine

Machines Bring Efficiency…and Empathy? Eric Topol Talks AI in Precision Medicine
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , Arizona , Eric-topol , Marag-aspinall , Scripps-research-translational-institute , Cambridge-healthtech-institute , Arizona-state-university , Precision-med , Ground-truths , Illumina-ventures

Assessing the Promise of AI in Oncology: Matching Patients With Clinical Trials

In this eighth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain how artificial intelligence tools are being developed to match the right patient to the right drug on the right clinical trial.

Toufica-kachaamy , Douglas-flora , Holy-grail , Massive-bio , Clinical-trials , Artificial-intelligence , Ai , City-of-hope , St-elizabeth-healthcare , D , Ssbb

FDA Grants Orphan Drug Designation to LP-284 for High-Grade B-Cell Lymphomas

The FDA has granted orphan drug designation to LP-284 for use in the treatment of patients with high-grade B-cell lymphoma harboring MYC and BCL2 rearrangements.

Houston , Texas , United-states , Lantern-pharma-inc , Lantern-pharma , Lp-284- , High-gradeb-cell-lymphoma- , Lymphoma , Blood-cancer , Hgbl , Precision-med

Reviewing Best Practices in the Surgical Management of Breast Cancer: Post-Surgery Outcomes in Stage IV Disease

In this final episode of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, shed light on clinical outcomes following surgery of the primary tumor in patients with stage IV breast cancer.

Turkey , United-states , Florida , American , Gladys-giron , Cristina-lopez , Atilla-soran , Baptist-health-south-florida , Reviewing-best-practices , Surgical-management , Breast-cancer , Cristina-lopez-pe

Assessing the Promise of AI in Oncology: Potential Role in Cancer Screening, Diagnosis, Staging

In this sixth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss potential opportunities to leverage artificial intelligence tools in cancer screening, diagnosis, staging, and prognosis.

United-states , America , American , Google-deepmind , Toufica-kachaamy , American-joint-committee-on-cancer , Douglas-flora , Exact-sciences , American-joint-committee , Oncchats , Onclive , Precision-med

DLL3-Targeting Agents Are Poised to Fill Unmet Needs in SCLC

Expression of DLL3, an inhibitor ligand of the Notch pathway associated with tumorigenesis, has emerged as a target of interest for drug development.

United-states , Germany , Dresden , Sachsen , American , Martin-wermke , University-hospital-carl-gustav-carus , American-society-of-clinical-oncology , Early-clinical-trial-unit , National-center , Tumor-diseases-dresden , Data-emerges-for

Leveraging Endoscopic Ultrasound in Pancreatic Cancer: Finding Actionable Mutations

In this second episode of OncChats: Leveraging Endoscopic Ultrasound in Pancreatic Cancer, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Tamas A. Gonda, MD, discuss the techniques used such as endoscopic ultrasound–guided biopsies to collect adequate tissue to perform genomic analyses in pancreatic cancer, and the likelihood for finding actionable mutations in this population.

Madappa-kundranda , Toufica-kachaamy , Tamasa-gonda , Banner-md-anderson-cancer-center , Leveraging-endoscopic-ultrasound , Pancreatic-cancer , Cancer-center , Endoscopy , Endoscopic-ultrasound , Actionable-mutations , Precision-med , Oncchats